Advertisement

Topics

Alnylam, with positive data on second gene-silencing drug, plans filing to FDA

09:14 EDT 27 Sep 2018 | STAT

Fresh off its first drug approval, Alnylam plans filing to FDA for approval of a second gene-silencing therapy.

Original Article: Alnylam, with positive data on second gene-silencing drug, plans filing to FDA

NEXT ARTICLE

More From BioPortfolio on "Alnylam, with positive data on second gene-silencing drug, plans filing to FDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...